Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | BRD4 | O60885 | 1/20 | 0.40 |
| ▸ | BRD2 | P25440 | 1/20 | 0.40 |
| ▸ | BRD3 | Q15059 | 1/20 | 0.40 |
| ▸ | XIAP | P98170 | 1/20 | 0.39 |
| ▸ | CA1 | P00915 | 1/20 | 0.39 |
| ▸ | CA2 | P00918 | 1/20 | 0.39 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.39 |
| ▸ | KCNQ2 | O43526 | 1/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CCKBR | P32239 | 3/20 | 0.36 |
| ▸ | TSHR | P16473 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | PREP | P48147 | 2/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6178982 | 0.90 | ACE (0.41) | ALDH1A1PREP | |
| SCHEMBL6179084 | 0.85 | CA1 (0.32) | BRD4BRD2BRD3XIAPCA1 | |
| SCHEMBL7959523 | 0.81 | TSHR (0.39) | ALDH1A1TP53CCKBRTSHR | |
| SCHEMBL6177308 | 0.80 | PARP1 (0.40) | ALDH1A1CCKBRPREP | |
| SCHEMBL6177621 | 0.80 | CCKBR (0.49) | CCKBR | |
| SCHEMBL6176498 | 0.79 | CCKBR (0.44) | CCKBR | |
| SCHEMBL6179330 | 0.79 | CCKBR (0.47) | TP53CCKBRTSHR | |
| SCHEMBL6176919 | 0.79 | CCKBR (0.42) | CCKBR | |
| SCHEMBL17557005 | 0.78 | CA1 (0.47) | CA1CA2ACHEALDH1A1KCNQ2 | |
| SCHEMBL16059873 | 0.78 | CA1 (0.47) | CA1CA2ACHEALDH1A1KCNQ2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6239131-B1 | WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | disclosed |